Literature DB >> 10874884

The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.

J D Hoyer1, C A Hanson, R Fonseca, P R Greipp, G W Dewald, P J Kurtin.   

Abstract

We identified 24 cases of multiple myeloma with the t(11;14)(q13;q32). In 22 cases, the t(11;14)(q13;q32) was part of a complex karyotype, and in 2 cases it was an isolated abnormality. All patients had clinical and laboratory features consistent with multiple myeloma. The median degree of plasma cell involvement in the bone marrow was 60%, and in 10 cases, the plasma cells had a lymphoplasmacytoid appearance. Of the 24 cases, 21 had intermediate or high proliferative rates based on labeling index studies. Immunohistochemical studies performed on all bone marrow biopsy specimens showed strong cyclin D1 nuclear positivity in 19 cases. There also was strong cyclin D1 nuclear positivity found in 6 of 30 additional cases without the t(11;14)(q13;q32) demonstrated by routine cytogenetics. The t(11;14)(q13;q32) in multiple myeloma results in overexpression of the cyclin D1 protein, which can be demonstrated by immunohistochemical stain. The cyclin D1 stain results in the additional cases of multiple myeloma suggest that the t(11;14)(q13;q32) may be more common than previously thought and may be missed by routine cytogenetics, particularly if the proliferative rate is low.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10874884     DOI: 10.1309/4W8E-8F4K-BHUP-UBE7

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  27 in total

Review 1.  Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection.

Authors:  Narittee Sukswai; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2019-10       Impact factor: 3.952

2.  Diagnostic and treatment hurdles in plasma cell myeloma with t(11;14) translocation: A case report.

Authors:  Shun Yin Kong; Wing Kit Lam; Ka Shu Li; Ka Pik Yeung; Chung Yin Ha; Ho Kei Lai; Hay Nun Chan; Yiu Ming Yeung; Sze Fai Yip
Journal:  Mol Clin Oncol       Date:  2018-04-24

Review 3.  Risk Stratification in Multiple Myeloma in Indian Settings.

Authors:  Rajan Kapoor; Rajiv Kumar; A P Dubey
Journal:  Indian J Hematol Blood Transfus       Date:  2019-12-14       Impact factor: 0.900

4.  Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.

Authors:  Joel F Gradowski; Rachel L Sargent; Fiona E Craig; Kathleen Cieply; Kim Fuhrer; Carol Sherer; Steven H Swerdlow
Journal:  Am J Clin Pathol       Date:  2012-07       Impact factor: 2.493

5.  Characterization and use of the novel human multiple myeloma cell line MC-B11/14 to study biological consequences of CRISPR-mediated loss of immunoglobulin A heavy chain.

Authors:  Denise K Walters; Bonnie K Arendt; Renee C Tschumper; Xiaosheng Wu; Diane F Jelinek
Journal:  Exp Hematol       Date:  2017-10-13       Impact factor: 3.084

6.  Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.

Authors:  Leticia Quintanilla-Martinez; Marcus Kremer; Katja Specht; Julia Calzada-Wack; Michaela Nathrath; Robert Schaich; Heinz Höfler; Falko Fend
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 7.  The classification of lymphomas: a new beginning or the end of an era?

Authors:  A S Jack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-07       Impact factor: 9.236

Review 8.  What is the significance of monoclonal gammopathy of undetermined significance?

Authors:  Catherine Atkin; Alex Richter; Elizabeth Sapey
Journal:  Clin Med (Lond)       Date:  2018-10       Impact factor: 2.659

9.  Clinical, immunophenotypic, and genetic characterization of small lymphocyte-like plasma cell myeloma: a potential mimic of mature B-cell lymphoma.

Authors:  Amy Heerema-McKenney; James Waldron; Steven Hughes; Fenghuang Zhan; Jeffery Sawyer; Bart Barlogie; John D Shaughnessy
Journal:  Am J Clin Pathol       Date:  2010-02       Impact factor: 2.493

10.  Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma.

Authors:  Koji Sasaki; Gary Lu; Rima M Saliba; Qaiser Bashir; Chitra Hosing; Uday Popat; Nina Shah; Simrit Parmar; Yvonne Dinh; Sairah Ahmed; Elizabeth J Shpall; Partow Kebriaei; Jatin J Shah; Robert Z Orlowski; Richard Champlin; Muzaffar H Qazilbash
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-31       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.